Tradition Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-462
Closed -$15K 441
2023
Q4
$15K Buy
462
+50
+12% +$1.36K ﹤0.01% 905
2023
Q3
$11K Sell
412
-7
-2% -$229 ﹤0.01% 984
2023
Q2
$14K Hold
419
﹤0.01% 957
2023
Q1
$13K Hold
419
﹤0.01% 925
2022
Q4
$12K Hold
419
﹤0.01% 858
2022
Q3
$14K Hold
419
﹤0.01% 837
2022
Q2
$13K Hold
419
﹤0.01% 750
2022
Q1
$19K Buy
419
+9
+2% +$429 ﹤0.01% 723
2021
Q4
$25K Buy
410
+7
+2% +$484 ﹤0.01% 676
2021
Q3
$30K Buy
403
+5
+1% +$420 ﹤0.01% 637
2021
Q2
$37K Hold
398
0.01% 610
2021
Q1
$35K Sell
398
-217
-35% -$21.5K 0.01% 509
2020
Q4
$57K Buy
+615
New +$49K 0.01% 386

Other funds holding ARKG

Tradition Wealth Management's ARKG Position: Q1 2024 in Review

Tradition Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2024, closing a stake of 462 shares — an estimated $15K sold.

Tradition Wealth Management first reported a position in ARKG in Q4 2020 and held it in 13 quarters. The position peaked at $57K in Q4 2020. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

  • Tradition Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2024 after selling out during the quarter.
  • Tradition Wealth Management sold 462 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $15K.
  • Tradition Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 13 quarters.
  • Tradition Wealth Management's ARK Genomic Revolution ETF position peaked at $57K in Q4 2020.
  • 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on Tradition Wealth Management's 13F filing for Q1 2024, filed 13 May 2024.